IM Cannabis
Biotechnology, Cannabis, Community And Lifestyle · 435 employees
IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers. IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets. The ecosystem created through its international operations leverages the Company's unique data-dr
Funding history
- Pre-Seed — $225K — Jul 2026
- Debt Financing — $2.2M — Jan 2026
- Post-IPO Equity — $4.1M — Jul 2025
- Pre-Seed — $27K — Nov 2024
- Venture - Series Unknown — $302K — Jul 2020
Recent signals
- Jul 01, 2026: Raised $225K in Pre-Seed
- Mar 17, 2026: Acquired IMC to acquire 51% of Blackaxe Technologies
- Jan 26, 2026: Raised $2.2M in Debt Financing
- Dec 12, 2025: IM Cannabis Corp. Appoints Asi Levi as Chief Financial Officer
- Jul 31, 2025: Raised $4.1M in Post-IPO Equity
- Nov 20, 2024: Raised $27K in Pre-Seed
- Mar 30, 2022: Acquired Im Cannabis Closes Previously Announced Acquisition Of Oranim Pharm, Jerusalem'S Leading Medical Cannabis Pharmacy
- Jul 09, 2020: Raised $302K in Venture - Series Unknown
See plans & pricing → Track IM Cannabis’s funding, hiring, and signals — with verified contacts — on Fundz.